Roche
Search results
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
Novartis Singapore. Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022. [4] [5]
Mar 15, 2024 · SINGAPORE - Swiss pharmaceutical giant Novartis is spending US$256 million (S$342.3 million) to expand its biopharmaceutical manufacturing plant here. The enlarged facility is expected to be ...
Mar 15, 2024 · Since 1986, Novartis and Singapore have built a strong, successful and wide-ranging partnership that has enabled people around the world to lead healthier lives. Novartis has invested more than US$1 billion in Singapore over the years, and I am happy to see you further deepen your presence here.
Sep 28, 2021 · Novartis receives approval in Singapore for LEQVIO® (inclisiran), an innovative medication that changes the treatment paradigm for patients with high cholesterol. Sep 28, 2021. Leqvio® (inclisiran) is an innovative medicine that can change how low-density lipoprotein cholesterol (LDL-C) or commonly known as bad cholesterol is ...
May 23, 2024 · Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative ...
Find the latest Novartis AG (NVS) stock quote, history, news and other vital information to help you with your stock trading and investing.
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
Mar 15, 2024 · Novartis breaks ground on $256 million expansion of biopharmaceutical manufacturing plant in Singapore. Investment focuses on deploying digital and automation solutions to boost productivity, efficiency, and workforce skills.
